Mark Augusti News Today

Conformis and restor3d have announced a merger agreement under which restor3d will acquire all outstanding Conformis common stock at $2.27 per share, according to a company press release.

DURHAM, N.C. and BILLERICA, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. (NASDAQ:CFMS) announced today that they have entered into a definitive merger agreement under which restor3d, a

Restor3d and Conformis (Nasdaq:CFMS) announced yesterday that they have entered into a definitive merger agreement.

Conformis, Inc. (NASDAQ: CFMS) shares are shooting higher after the company announced a 

Operator: Good morning, and welcome to the First Quarter 2023 Earnings Conference Call for Conformis, Incorporated. My name is Tanya, and I will be your conference operator today.

BILLERICA, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial

Operator: Good afternoon, and welcome to the Fourth Quarter and Full Year 2022 Earnings Conference Call for Conformis, Inc. My name is Josh, and I will be your conference operator today.

Conformis (Nasdaq:CFMS) today announced the first procedure performed with its new Actera hip system for hip reconstruction.

Conformis (Nasdaq:CFMS) today announced the full commercial launch of its new made-to-measure Imprint knee system.

Conformis (NSDQ:CFMS) today posted third-quarter results that missed the earnings consensus on Wall Street but beat revenue estimates.